Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 34.04 and traded as high as GBX 45. Cambridge Cognition shares last traded at GBX 45, with a volume of 2,891 shares.
Analyst Ratings Changes
Separately, Panmure Gordon restated a “buy” rating and set a GBX 56 price objective on shares of Cambridge Cognition in a research report on Monday, January 19th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, Cambridge Cognition has a consensus rating of “Buy” and an average target price of GBX 56.
View Our Latest Research Report on Cambridge Cognition
Cambridge Cognition Trading Down 0.6%
About Cambridge Cognition
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Featured Stories
- Five stocks we like better than Cambridge Cognition
- CSE: ALEN.U is targeting a fast-growing digital wellness market
- New Copper-Rich “Kraken” Zone Discovered
- Your name isn’t on our protected list yet
- Silver paying 20% dividend. Plus 68% share gains
- Elon Musk: This Could Turn $100 into $100,000
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
